中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2016/08/22 | 3,280 | 3,310 | 3,245 | 3,270 | +5 | +0.2% | 1,036,600 |
| 2016/08/19 | 3,340 | 3,355 | 3,190 | 3,265 | -110 | -3.3% | 1,981,200 |
| 2016/08/18 | 3,440 | 3,460 | 3,375 | 3,375 | -100 | -2.9% | 1,183,700 |
| 2016/08/17 | 3,490 | 3,500 | 3,445 | 3,475 | -25 | -0.7% | 891,400 |
| 2016/08/16 | 3,560 | 3,560 | 3,500 | 3,500 | -50 | -1.4% | 969,500 |
| 2016/08/15 | 3,600 | 3,620 | 3,520 | 3,550 | -130 | -3.5% | 760,000 |
| 2016/08/12 | 3,650 | 3,680 | 3,610 | 3,680 | +80 | +2.2% | 957,800 |
| 2016/08/10 | 3,600 | 3,625 | 3,560 | 3,600 | +5 | +0.1% | 742,400 |
| 2016/08/09 | 3,600 | 3,630 | 3,560 | 3,595 | -15 | -0.4% | 630,200 |
| 2016/08/08 | 3,615 | 3,625 | 3,555 | 3,610 | +65 | +1.8% | 765,100 |
| 2016/08/05 | 3,615 | 3,660 | 3,515 | 3,545 | -115 | -3.1% | 1,192,800 |
| 2016/08/04 | 3,700 | 3,720 | 3,610 | 3,660 | -50 | -1.3% | 1,101,100 |
| 2016/08/03 | 3,655 | 3,745 | 3,655 | 3,710 | -70 | -1.9% | 1,110,500 |
| 2016/08/02 | 3,815 | 3,855 | 3,780 | 3,780 | -80 | -2.1% | 874,100 |
| 2016/08/01 | 3,825 | 3,895 | 3,810 | 3,860 | -5 | -0.1% | 868,700 |
| 2016/07/29 | 3,810 | 3,895 | 3,775 | 3,865 | ±0 | ±0% | 1,356,200 |
| 2016/07/28 | 3,960 | 3,970 | 3,835 | 3,865 | -65 | -1.7% | 815,600 |
| 2016/07/27 | 3,950 | 4,000 | 3,930 | 3,930 | +45 | +1.2% | 1,640,000 |
| 2016/07/26 | 3,855 | 3,895 | 3,830 | 3,885 | -10 | -0.3% | 879,800 |
| 2016/07/25 | 3,980 | 3,980 | 3,880 | 3,895 | -5 | -0.1% | 1,022,200 |
| 2016/07/22 | 3,790 | 3,900 | 3,780 | 3,900 | +180 | +4.8% | 1,450,600 |
| 2016/07/21 | 3,815 | 3,825 | 3,695 | 3,720 | -45 | -1.2% | 851,300 |
| 2016/07/20 | 3,800 | 3,825 | 3,730 | 3,765 | -65 | -1.7% | 1,127,500 |
| 2016/07/19 | 3,835 | 3,850 | 3,775 | 3,830 | +30 | +0.8% | 1,517,300 |
| 2016/07/15 | 3,860 | 3,880 | 3,790 | 3,800 | -75 | -1.9% | 1,176,600 |
| 2016/07/14 | 3,795 | 3,880 | 3,780 | 3,875 | +75 | +2% | 960,800 |
| 2016/07/13 | 3,910 | 3,910 | 3,785 | 3,800 | -40 | -1% | 955,400 |
| 2016/07/12 | 3,835 | 3,890 | 3,825 | 3,840 | +40 | +1.1% | 882,300 |
| 2016/07/11 | 3,750 | 3,835 | 3,750 | 3,800 | +120 | +3.3% | 764,600 |
| 2016/07/08 | 3,755 | 3,810 | 3,675 | 3,680 | -35 | -0.9% | 1,444,900 |
| 2016/07/07 | 3,725 | 3,750 | 3,690 | 3,715 | +50 | +1.4% | 843,600 |
| 2016/07/06 | 3,660 | 3,705 | 3,615 | 3,665 | -30 | -0.8% | 1,061,300 |
| 2016/07/05 | 3,705 | 3,725 | 3,660 | 3,695 | -55 | -1.5% | 675,000 |
| 2016/07/04 | 3,700 | 3,780 | 3,685 | 3,750 | +20 | +0.5% | 980,400 |
| 2016/07/01 | 3,665 | 3,745 | 3,665 | 3,730 | +95 | +2.6% | 1,019,000 |
| 2016/06/30 | 3,640 | 3,670 | 3,575 | 3,635 | +25 | +0.7% | 1,351,600 |
| 2016/06/29 | 3,645 | 3,665 | 3,575 | 3,610 | ±0 | ±0% | 1,237,000 |
| 2016/06/28 | 3,455 | 3,645 | 3,415 | 3,610 | +65 | +1.8% | 1,133,600 |
| 2016/06/27 | 3,420 | 3,555 | 3,410 | 3,545 | +205 | +6.1% | 1,516,200 |
| 2016/06/24 | 3,645 | 3,670 | 3,295 | 3,340 | -290 | -8% | 1,705,300 |
| 2016/06/23 | 3,635 | 3,700 | 3,590 | 3,630 | +15 | +0.4% | 815,400 |
| 2016/06/22 | 3,630 | 3,650 | 3,575 | 3,615 | -30 | -0.8% | 688,100 |
| 2016/06/21 | 3,535 | 3,660 | 3,510 | 3,645 | +100 | +2.8% | 1,117,700 |
| 2016/06/20 | 3,590 | 3,610 | 3,525 | 3,545 | -20 | -0.6% | 1,575,700 |
| 2016/06/17 | 3,625 | 3,650 | 3,560 | 3,565 | +5 | +0.1% | 2,432,500 |
| 2016/06/16 | 3,640 | 3,665 | 3,540 | 3,560 | -105 | -2.9% | 1,021,800 |
| 2016/06/15 | 3,650 | 3,675 | 3,630 | 3,665 | -5 | -0.1% | 740,000 |
| 2016/06/14 | 3,740 | 3,740 | 3,630 | 3,670 | -50 | -1.3% | 904,700 |
| 2016/06/13 | 3,790 | 3,805 | 3,700 | 3,720 | -95 | -2.5% | 752,700 |
| 2016/06/10 | 3,850 | 3,850 | 3,785 | 3,815 | -30 | -0.8% | 1,677,000 |
2201～
2250
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 627,000円 | +1.7% | +5.0% | 3.99% | 25.17倍 | 5.20倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 武 田 | 458,900円 | -1.1% | +75.3% | 4.36% | 31.79倍 | 1.05倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 第一三共 | 370,000円 | +6.0% | +4.0% | 2.11% | 22.83倍 | 4.22倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 大塚ＨＤ | 806,600円 | +2.2% | +28.0% | 1.74% | 12.91倍 | 1.56倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 169,200円 | +0.9% | +380.2% | 4.61% | 23.31倍 | 2.00倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
